Preprint on Alzheimer's drug deaths ignites author dispute.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39541464.
- Also identified by DOI 10.1126/science.adu5824.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Co-authors say preliminary data on lecanemab fatalities don't support the paper's claims.
Medical subject headings
- Alzheimer Disease
- Antibodies, Monoclonal, Humanized